International Flavors (IFF) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

International Flavors (IFF) reported $2.77 billion in revenue for the quarter ended December 2024, representing a year-over-year increase of 2.5%. EPS of $0.97 for the same period compares to $0.72 a year ago.The reported revenue represents a surprise of +3.94% over the Zacks Consensus Estimate of $2.67 billion. With the consensus EPS estimate being $0.78, the EPS surprise was +24.36%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how International Flavors performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Net Sales- Nourish: $1.41 billion versus the five-analyst average estimate of $1.37 billion. The reported number represents a year-over-year change of +1.2%. Net sales- Scent: $579 million versus the five-analyst average estimate of $555.31 million. The reported number represents a year-over-year change of +0.2%. Net Sales- Pharma Solutions: $228 million compared to the $206.76 million average estimate based on five analysts. The reported number represents a change of +12.3% year over year. Net Sales- Health & Biosciences: $553 million compared to the $532.95 million average estimate based on five analysts. The reported number represents a change of +4.7% year over year. Adjusted Operating EBITDA- Nourish: $170 million versus the five-analyst average estimate of $167.93 million. Adjusted Operating EBITDA- Pharma Solutions: $47 million compared to the $31.04 million average estimate based on five analysts. Adjusted Operating EBITDA- Scent: $97 million versus the five-analyst average estimate of $103.11 million. Adjusted Operating EBITDA- Health & Biosciences: $157 million versus the five-analyst average estimate of $150.64 million. View all Key Company Metrics for International Flavors here>>>Shares of International Flavors have returned +0.8% over the past month versus the Zacks S&P 500 composite's +4.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report International Flavors & Fragrances Inc. (IFF): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks